Identifying mutator phenotypes among fluoroquinolone-resistant ACCEPTED. Jeffrey N. Weiser M.D. 402A Johnson Pavilion. Department of Microbiology
|
|
- Donald Jenkins
- 5 years ago
- Views:
Transcription
1 AAC Accepts, published online ahead of print on 30 July 2007 Antimicrob. Agents Chemother. doi: /aac Copyright 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved. Identifying mutator phenotypes among fluoroquinolone-resistant strains of Streptococcus pneumoniae using fluctuation analysis Carolyn V. Gould 1, Paul D. Sniegowski 2, Mikhail Shchepetov 3, Joshua P. Metlay 1,4, and Jeffrey N. Weiser 3 * Departments of Microbiology 3, Medicine 1, and Biology 2, University of Pennsylvania Philadelphia, Pennsylvania 19104, 4 Veteran s Administration Medical Center 4, Philadelphia, Pennsylvania, Address for correspondence: Jeffrey N. Weiser M.D. 402A Johnson Pavilion Department of Microbiology University of Pennsylvania Philadelphia, PA tel , fax weiser@mail.med.upenn.edu Running Title: Mutators among resistant pneumococci Current address of Carolyn V. Gould is: Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Mailstop A-35, Atlanta, GA
2 Abstract The occurrence of mutator phenotypes among laboratory-generated and clinical levofloxacin-resistant strains of Streptococcus pneumoniae was determined using fluctuation analysis. The in vitro selection for levofloxacin-resistant mutants of strain D39, each with point mutations in both gyra and parc or pare, was not associated with a significant change in the mutation rate. Two of eight clinical isolates resistant to levofloxacin (MIC>8 µg/ml) had estimated mutation rates of 1.2 x 10-7 and 9.4 x 10-8 mutations per cell division, indicating potential mutator phenotypes, when compared to strain D39, which had an estimated mutation rate of 1.4 x 10-8 mutations per cell division. The levofloxacin-resistant isolates with the highest mutation rates showed evidence of dysfunctional mismatch repair and contained missense mutations in mut genes at otherwise highly conserved sites. The association of hypermutability in levofloxacinresistant S. pneumoniae clinical isolates with mutations in DNA mismatch repair genes provides further evidence that mismatch repair mutants may have a selective advantage in the setting of antibiotic pressure, facilitating the development of further antibiotic resistance. 2
3 Introduction Resistance of Streptococcus pneumoniae to penicillin and other commonly used agents has led to increasing dependence on newer classes of antimicrobials such as fluoroquinolones for serious infections including pneumonia (7, 15). Although fluoroquinolone resistance in pneumococci is still relatively uncommon, surveillance studies have noted increasing resistance concomitant with increasing use of fluoroquinolones (3, 8). Fluoroquinolones directly inhibit DNA synthesis by targeting two tetrameric enzymes involved in DNA replication, topoisomerase IV, encoded by the genes parc and pare, and DNA gyrase, encoded by gyra and gyrb (9). Fluoroquinolone resistance most commonly develops as a result of spontaneous point mutations in specific locations within these genes, referred to as quinolone resistance-determining regions (QRDRs). Reduced susceptibility to fluoroquinolones occurs in a step-wise manner(10). Spontaneous mutations usually occur first in either parc or gyra, depending on the selecting fluoroquinolone, and arise at frequencies of 10-6 to 10-9 (30). First-step mutants usually do not have detectable antibiotic resistance, but if progeny of first-step mutants acquire a second mutation in the QRDR of the other target enzyme, strains with reduced fluoroquinolone sensitivity will occur. Furthermore, previous studies have suggested that first-step mutants may acquire a second mutation at a higher rate (5). Antibiotic selection is known to enrich bacterial cultures for mutator phenotypes, subpopulations of bacteria with higher mutation rates(16). Since most mutations are deleterious, mutator alleles are likely to have negative effects on fitness. However, in an evolving clonal population, a deleterious mutator can rise to high 3
4 frequency (hitch-hike) in association with adaptive mutations (6). Mismatch repair mutants are the most commonly observed mutators in bacterial populations under selective conditions (32). The hexa-hexb mismatch repair genes in S. pneumoniae, equivalent to the muts-mutl genes in Escherichia coli, play a major role in preventing spontaneous mutations during bacterial replication. Pneumococci defective in hexa have been reported to display a mutator phenotype with a10-fold increase in mutation frequency (20). Moreover, hexa - mutant strains of S. pneumoniae were selected preferentially over the wild type ancestor during exposure to low cefotaxime concentrations, demonstrating a selective advantage of the hypermutable strain during antibiotic exposure (20). We hypothesized that S. pneumoniae with a mutator phenotype could be identified among populations that had undergone selection for antibiotic resistance. We focused on fluoroquinolone resistance, since the two-step selection process might be facilitated by a mutator phenotype. Methods Bacterial strains and culture conditions D39, a serotype 2 strain that was isolated prior to the use of antibiotics, was used as a negative, non-mutator control. A Hex- deficient mutant, which has the D39 background (35), was used as a putative, hypermutator control for the assay. Laboratorygenerated levofloxacin-resistant isolates were produced by sequential passages of the D39 strain on selective media with 1 µg/ml followed by 4 µg/ml of levofloxacin. The mutants were characterized with respect to mutations in the QRDRs of genes parc, pare, 4
5 gyra, and gyrb genes by methods previously described (23). Clinical isolate susceptibilities were determined by the disk diffusion method, according to the National Committee for Clinical Laboratory Standards(19). Strains with zone diameters of 13 mm, corresponding to an MIC of 8 µg/ml, were considered to be levofloxacin-resistant. The MICs of levofloxacin for resistant isolates as well as laboratory strains were confirmed by use of the Etest (AB Biodisk), performed according to the manufacturer s recommendations. Fluctuation analysis. The fluctuation assay consists of determining the distribution of mutant numbers across multiple parallel cultures. The mutation rate is determined by analyzing that distribution. The probable number of mutational events per culture (m) that gave rise to the distribution of mutants observed is estimated. m can be converted to mutation rate, µ, by dividing it by some function of the number of cells at risk (28). For the assay, ten parallel cultures per strain were first inoculated with a small number (~ 10 3 ) of bacterial cells. To do this, frozen starter cultures were inoculated into liquid THY media, allowed to grow to steady state at 37 C and diluted 100-fold into prewarmed media to achieve an initial homogeneous population. Cultures were again grown to steady state and then subcultured into pre-warmed THY media in 24-well microtiter plates, diluting by 1/10 4 for a total volume of 500 µl per well. The initial inoculum (N 0 ) was confirmed by plating an appropriate dilution of representative cultures on nonselective media. Cultures were incubated in candle jars at 37ºC to achieve generations (7-8 hrs for a strain with doubling time of ~40 min). The average final 5
6 number of cells (N t ) per strain was determined by plating an appropriate dilution of two cultures on nonselective media. The number of optochin-resistant mutants in each culture was determined by plating the entire culture on selective medium containing 8 µg/ml of optochin and incubating for 48 hours. Loss of sensitivity to the antimicrobial optochin (ethylhydrocupreine) to which the pneumococcus is normally sensitive because of a H+-ATPase activity conferred by a F 0 F 1 class ion transport ATPase occurs through point mutations in atpc as previously described(24). Because simultaneous full fluctuation tests of all strains with large numbers of cultures per strain represented a prohibitive amount of work, we used a design in which we grew "blocks" of 10 cultures per strain for all strains at the same time, then repeated each such block three times. In this way, we controlled for any temporal variation in environmental effects on mutation rates by growing all strains simultaneously rather than sequentially. Results from the three blocks were pooled into single data sets (representing 30 cultures per strain) for analysis of the mutation rate in each strain. Calculation and statistical comparison of mutation rates from the fluctuation test data were carried out using a computer program written in the Sniegowski laboratory (31, 33). The program makes an initial estimate of the rate based on either the P(0) method of Luria and Delbrück or the median method of Lea and Coulson, and then it refines this initial estimate by searching around it for the rate with the best fit to the full set of observed data based on the Luria-Delbrück distribution generating algorithm of Ma et al.(11, 13, 14). Confidence limits on the mutation rate estimate obtained in this way are determined using standard theory for the variance of a maximum likelihood estimate, which agrees closely with a method proposed by Stewart(34). The program, FT, and 6
7 descriptive files for its use are available for download at Tranformation experiments Quantification of mismatch repair was carried out as previously described(1). Briefly, transformation efficiency was assessed among the isolates using donor S. pneumoniae DNA carrying a marker incorporated at low efficiency (novobiocin) and compared to another marker incorporated at high efficiency (streptomycin). An increased ratio of novobiocin to streptomycin resistant transformants is characteristic of Hex- deficient mismatch repair mutants. Transformation frequencies were expressed as the mean of three determinations for each marker. Sequence analysis of mut genes Genomic DNA from isolates 2530 and 1237, with increased average mutation rates, was used to amplify the entire mutl (hexb), muts (hexa), mutx and muty genes using primers based on the TIGR4 strain whole genome sequence (cmr.tigr.org/tigrscripts/cmr/genomepage.cgi?database=bsp). Products generated following amplification with Vent (exo+) DNA Polymerase (New England Biolabs, Beverly, Massachusetts) were used to obtain DNA sequence. Sequences were also generated for isolates 0455 and 3386, without increased average mutations rates, for comparison. Gene sequences among the four isolates were compared to current database entries, searchable S. pneumoniae genomes ( and previously described hexa and hexb sequence variants(18). All reported mutations 7
8 were confirmed using independently derived amplification products. Sequences from mutator isolates 2530 and 1237 were deposited in Genbank. Accession numbers (EF ). Results We tested indirectly for the involvement of mutator phenotypes in the development of high-level fluoroquinolone resistance by assaying fluoroquinolone- resistant clinical isolates and in vitro produced resistant mutants of S. pneumoniae for elevated mutation rates. We measured and compared mutation rates in resistant and sensitive isolates by assaying for spontaneous resistance to optochin, the consequence of a non-qrdr point mutation, using fluctuation analysis (13, 24). First, we tested whether the QRDR point mutations seen in fluoroquinolone- resistant pneumococci alter mutation rates. The two-step in vitro selection for spontaneous resistance to the respiratory fluoroquinolone levofloxacin in strain D39 was not associated with a significant change in its mutation rate. This was the case for three independently derived high-level fluoroquinolone-resistant mutants of D39 (D39-2,-3,-19), each with point mutations in both gyra and parc or pare, encompassing the commonly observed mutations conferring resistance to fluoroquinolones in clinical isolates (Table 1). This result showed that these changes in DNA gyrase (gyra) and topoisomerase IV (parc or pare) do not themselves alter mutation rates in S. pneumoniae. We then assessed mutation rates in eight clinical isolates with resistance to the fluoroquinolone, levofloxacin (MIC> 8 µg/ml). Among this group the average mutation 8
9 rate varied widely between 1.2 x 10-7 to 2.7 x 10-8 mutations per cell division. Again there was no association between the specific sequence changes in gyra or parc and the frequency of spontaneous mutations. For two isolates the average mutation rates were significantly greater than that of the control strain D39 (Fig. 1). This suggested that two of the eight FQ-resistant isolates, 2530 and 1237, with average mutation rates of 1.2 x 10-7 and 9.1 x 10-8 respectively, may have mutator phenotypes. These were also compared to eight recent fluoroquinolone -sensitive clinical isolates where the mean average mutation rate was 2.0 x 10-8 (range x 10-8 ). To further characterize these two isolates with higher average mutation rates, we determined whether strains 2530 and 1237 were affected in mismatch repair function to account for their hypermutability. Both strain 2530 and 1237 showed increased transformation frequency with a selectable chromosomal marker that is taken up at low efficiency in the D39 non-mutator control due to its proficient DNA mismatch repair function (Table 2). The increased ratio of novobiocin- to streptomycin-resistant transformants of >1.0 in isolates 2530 and 1237 was typical of S. pneumoniae defective mismatch repair systems(1). Because the phenotype of isolates 2530 and 1237 resembled that of a Hex- mutant (average mutation rate of 6.2 x 10-8 ), we analyzed their mutl (hexb) and muts (hexa) genes for alterations that could account for their higher mutation rates (Table 1). In addition, sequences from two other well-characterized genes that contribute to mismatch repair, mutx and muty, were determined. These four mut genes from strains 2530 and 1237 were sequenced and compared to two of the other isolates from this study without higher average mutation rates, 455 and 3386, as well as sequences in current databases 9
10 including 25 entries each for mutl, S and 12 entries each for mutx, Y. Mutations encoding missense changes were found in mutl, a highly conserved gene, for both hypermutable isolates and not in other strains or database entries (Table 2)(18). In addition, isolate 2530 contained mutations that would encode novel missense changes in each of the other Mut enzymes with multiple such changes within MutS. Discussion We postulated that the first step in selection for fluoroquinolone resistance enriches mutator phenotypes in S. pneumoniae populations and accelerates the development of high level resistance through second-step mutations. Even small increases in mutation rates (weak mutators) have been shown to have a measurable effect on the evolution of fluoroquinolone resistance in vitro (22). A single round of antibiotic selection can be sufficient to enrich mutator cells to majority frequency in a bacterial population (16); as a result, the population of cells can then more rapidly produce additional mutants that confer higher-level resistance or resistance to other antibiotics. Using a fluctuation assay, we screened a sample of levofloxacin-resistant and sensitive S. pneumoniae isolates for the presence of mutator phenotypes and found evidence for hypermutability among two clinical levofloxacin-resistant isolates. Fluctuation analysis was used because mutation rates, which measure the risk of mutation per cell division, are more accurate and reproducible than mutation frequencies, which measure the proportion of mutant colonies to the total number of organisms plated (5, 13). Analyses of mutation frequencies, although more amenable to use with large 10
11 numbers of strains, are inherently less reliable because of natural variation as documented by the classic 1943 study of Luria and Delbrück(13). Our approach, therefore, was to use a more rigorous test that accounts for this variability even though this precluded the analysis of large numbers of isolates. Since few mutators were identified among the 16 strains tested, our data are not sufficient to determine whether mutators occur more commonly among fluoroquinolone-resistant isolates. However, the identification of mutators among antibiotic resistant pneumococci offers a mechanism for the initial development of such strains. We would not necessarily expect that all resistant isolates would be mutators. Since S. pneumoniae is naturally competent for DNA uptake, the acquisition of resistance in a mutator strain could lead to spread of altered sequences among the population of non-mutators. A recent survey of fluoroquinolone-resistant isolates in the U.S. reported that these are predominantly genetically-diverse strains (26). A further source of mutated QRDRs is through horizontal transfer of DNA from other streptococci that coexist in the same environment (2). In addition, there is a fitness cost to maintaining the mutator phenotype. Once resistance is achieved in the setting of antibiotic pressure, the mutator phenotype may eventually be selected against and lost. Bacterial mutators may have a selective advantage in a changing environment where they can more easily adapt. Numerous laboratory experiments in E. coli have demonstrated that mutator phenotypes can rise to high frequency in bacterial cultures subjected to selective pressure (32). In the lungs of cystic fibrosis patients where prolonged antibiotic exposure and other selective pressures are increased, hypermutable strains of several bacterial species, including Pseudomonas aeruginosa, Staphylococcus 11
12 aureus, Haemophilus influenzae, and S. pneumoniae have been observed (4, 21, 25, 27). It has also been proposed that pathogenic bacterial isolates are more likely to be mutators (12, 21). Mutator phenotypes are caused by mutational defects in DNA replication and repair loci that elevate mutation rates genome-wide. Minor alterations in Mut enzymes may be associated with a strong mutator phenotype(31). Missense changes identified in Mut enzymes of the two isolates with increased average mutation rates in this study could account for their hypermutability and defective mismatch repair. The mismatch repair function of S. pneumoniae has generally been attributed to MutL or S, although other Mut enzymes likely contribute to this function. The N-glycosylase endonuclease protein MutY is deficient in repair of A/G mismatches such as occurs when 8-OxoG is generated from guanine during oxidative stress(29). In this regard, mutations noted in QRDRs in isolates 2530 and 1237 involve guanine (G A in gyra and parc). We have previously described the role of aerobic growth and endogenous hydrogen peroxide production on the high rate of spontaneous mutation characteristic of this species (24). Likewise, mutx encodes a dgtp pyrophosphohydrolase that when absent confers a mutator phenotype in S. pneumoniae (17). The data presented here, however, are not sufficient to define which of these mutations is responsible for the increased average mutation rate in isolates 2530 or 1237 or whether these mutations occur as a result rather than cause of their hypermutability. 12
13 Acknowledgements We thank Dr. P. Edelstein, Univ. Pennsylvania, for providing strains. This work was supported by grants from the U.S. Public Health Service to JNW (AI44231, and AI38446) and JPM (AI46645). 13
14 References 1. Balganesh, T., and S. Lacks Heteroduplex DNA mismatch repair system of Streptococcus pneumoniae: cloning and expression of the hexa gene. J Bacteriol 162: Balsalobre, L., M. J. Ferrandiz, J. Linares, F. Tubau, and A. G. de la Campa Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 47: Chen, D., A. McGeer, J. De Azavedo, and D. Low Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. New England Journal of Medicine 341: del Campo, R., M. I. Morosini, E. G. de la Pedrosa, A. Fenoll, C. Munoz- Almagro, L. Maiz, F. Baquero, R. Canton, and Spanish Pneumococcal Infection Study Network Population structure, antimicrobial resistance, and mutation frequencies of Streptococcus pneumoniae isolates from cystic fibrosis patients. Journal of Clinical Microbiology 43: Gillespie, S. H., L. L. Voelker, J. E. Ambler, C. Traini, and A. Dickens Fluoroquinolone resistance in Streptococcus pneumoniae: evidence that gyra mutations arise at a lower rate and that mutation in gyra or parc predisposes to further mutation. Microbial Drug Resistance 9:
15 6. Giraud, A., I. Matic, O. Tenaillon, A. Clara, M. Radman, M. Fons, and F. Taddei Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut. Science 291: Heffelfinger, J., S. Dowell, J. Jorgensen, K. Klugman, L. Mabry, D. Musher, J. Plouffe, A. Rakowsky, A. Schuchat, C. Whitney, and The Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group Management of community-acquired pneumonia in the era of pneumococcal resistance. Archives of Internal Medicine 160: Ho, P., T. Que, D. Tsang, T. Ng, K. Chow, and W. Seto Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong. Antimicrobial Agents and Chemotherapy 43: Hooper, D Mechanism of action of antimicrobials: focus on fluoroquinolones. Clinical Infectious Diseases 32(Suppl 1):S9-S Janoir, C., V. Zeller, M. Kitzis, N. Moreau, and L. Gutmann High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parc and gyra. Antimicrobial Agents and Chemotherapy 40: Lea, D., and C. Coulson The distribution of the numbers of mutants in bacterial populations. J Genetics 49: LeClerc, J. E., B. Li, W. L. Payne, and T. Cebula High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274:
16 13. Luria, S. E., and M. Delbrück Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28: Ma, W., G. Sandri, and S. Sarkar Analysis of the Luria-Delbrück distribution using discrete convolution powers. J Appl Prob 29: Mandell, L. A., J. G. Bartlett, S. F. Dowell, T. M. File, Jr., D. M. Musher, and C. Whitney Update on practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clinical Infectious Diseases 37: Mao, E. F., J. Lane, J. Lee, and J. H. Miller Proliferation of mutators in a cell population. Journal of Bacteriology 179: Mejean, V., C. Salles, L. C. Bullions, M. J. Bessman, and J. P. Claverys Characterization of the mutx gene of Streptococcus pneumoniae as a homologue of Escherichia coli mutt, and tentative definition of a catalytic domain of the dgtp pyrophosphohydrolases. Molecular Microbiology 11: Morosini, M. I., M. R. Baquero, J. M. Sanchez-Romero, M. C. Negri, J. C. Galan, R. del Campo, J. C. Perez-Diaz, and F. Baquero Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexa and hexb polymorphisms do not account for hypermutation. Antimicrobial Agents and Chemotherapy 47: National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing: 12th informational supplement. National Committee for Clinical Laboratory Standards, Wayne, PA. 16
17 20. Negri, M. C., M. I. Morosini, M. R. Baquero, R. del Campo, J. Blázquez, and F. Baquero Very low cefotaxime concentrations select for hypermutable Streptococcus pneumoniae populations. Antimicrobial Agents and Chemotherapy Oliver, A., R. Cantón, P. Campo, F. Baquero, and J. Blázquez High frequency of hypermutable Pseudomonas aeruginosa isolates in cystic fibrosis lung infection. Science Orlen, H., and D. Hughes Weak mutators can drive the evolution of fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 50: Pan, X., J. Ambler, S. Mehtar, and L. M. Fisher Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 40: Pericone, C. D., D. Bae, M. Shchepetov, T. McCool, and J. N. Weiser Short-sequence tandem and nontandem DNA repeats and endogenous hydrogen peroxide production contribute to genetic instability of Streptococcus pneumoniae. Journal of Bacteriology 184: Prunier, A. L., B. Malbruny, M. Laurans, J. Brouard, J. F. Duhamel, and R. Leclerc High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. Journal of Infectious Diseases 187:
18 26. Richter, S. S., K. P. Heilmann, S. E. Beekmann, N. J. Miller, C. L. Rice, and G. V. Doern The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations. Clinical Infectious Diseases 40: Roman, F., R. Cantón, M. Perez-Vazquez, F. Baquero, and J. Campos Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains. Journal of Clinical Microbiology 42: Rosche, W. A., and P. L. Foster Determining mutation rates in bacterial populations. Methods 20: Samrakandi, M. M., and F. Pasta Hyperrecombination in Streptococcus pneumoniae depends on an atypical muty homologue. Journal of Bacteriology 182: Sanders, C Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones. Clinical Infectious Diseases 32(Suppl 1):S1-S Shaver, A., and P. Sniegowski Spontaneously arising mutl mutators in evolving Escherichia coli populations are the result of changes in repeat length. J Bacteriol 185: Sniegowski, P. D., P. J. Gerrish, T. Johnson, and A. C. Shaver Evolution of mutation rates: separating causes from consequences. BioEssays 22: Sniegowski, P. D., P. J. Gerrish, and R. E. Lenski Evolution of high mutation rates in experimental populations of Escherichia coli. Nature 387:
19 34. Stewart, F Fluctuation tests: how reliable are the estimates of mutation rates? Genetics 137: Tiraby, J. G., and M. S. Fox Marker discrimination in transformation and mutation of pneumococcus. Proceedings of the National Academy of Sciences of the United States of America 70:
20 Table 1. Strain characteristics. Strain In vitro isolates Serotype Levofloxacin Mutations MIC (µg/ml) parc gyra pare Mutation rate Upper CL Lower CL Hex x x x 10-8 D S81F D435N 4.7 x x x 10-9 D >32 S79Y S81F x x x 10-9 D D83N S81Y x x x 10-9 Clinical isolates D x x x B 8 D83N S81F x x x B 8 S79F S81Y x x x N >32 S79Y S81F x x x >32 S79F S81F x x x 10-8 MIC, minimum inhibitory concentration; CL, 95% confidence limit. 20
21 Table 2. Phenotypic and genotypic analysis of DNA mismatch repair. Strain Transformants Missense Mutations* Nov R /Str R MutL MutS MutX MutY V216A I3T N134S S200G L209S P77S F302S T217A C424R S431G F272Y D Nov R, novobiocin-resistant (20µg/ml); Str R, streptomycin resistant (100µg/ml). *Deduced amino acid changes based on DNA sequence analysis are indicated by the position relative to the predicted initiation codon. 21
22 Figure Legend Fig. 1. Spontaneous mutation rate to optochin resistance measured by the fluctuation test among the levofloxacin-resistant (closed symbols) and sensitive (open symbols) strains. Mutation rates were determined for strain D39, three levofloxacin-resistant mutants of D39, a Hex- (mismatch repair defective) derivative of D39, and the recent clinical isolate indicated below. Values represent the average mutation rate from 30 independent cultures/experiments shown with upper and lower confidence limits. 22
23
Inside the Burch Lab: E. Coli and Triclosan Resistance. By: Pamela Lammonds
Inside the Burch Lab: E. Coli and Triclosan Resistance By: Pamela Lammonds Purpose and Goals of Research Concerns over infectious disease have risen in the past few years. In response to this concern,
More informationAssociation of gyra mutation in Mycobacterium tuberculosis isolates with phenotypic ofloxacin resistance detected by resazurin microtiter assay
Association of gyra mutation in Mycobacterium tuberculosis isolates with phenotypic ofloxacin resistance detected by resazurin microtiter assay Dr Asho Ali King Abdul Aziz University Jeddah, Saudi Arabia
More informationThe inactivation of intrinsic antibiotic resistance determinants widens the mutant. selection window for quinolones of Stenotrophomonas maltophilia.
AAC Accepts, published online ahead of print on 24 September 2012 Antimicrob. Agents Chemother. doi:10.1128/aac.01558-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 The
More informationSubinhibitory concentrations of penicillin increase the mutation rate to optochin resistance in Streptococcus pneumoniae
Journal of Antimicrobial Chemotherapy Advance Access published August 5, 2008 Journal of Antimicrobial Chemotherapy doi:10.1093/jac/dkn322 Subinhibitory concentrations of penicillin increase the mutation
More informationUniversity Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai Japan
AAC Accepts, published online ahead of print on 1 May 009 Antimicrob. Agents Chemother. doi:10.11/aac.0016-09 Copyright 009, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationLink between iron homeostasis, oxidative mutagenesis and antibiotic resistance evolution
Thesis of the PhD dissertation Link between iron homeostasis, oxidative mutagenesis and antibiotic resistance evolution Orsolya Katinka Méhi Supervisor: Dr. Csaba Pál, senior research associate PhD School
More information- BRIEF REPORT - Junyoung Kim a, Semi Jeon a, Hyungjun Kim a, Misun Park a, Soobok Kim b, Seonghan Kim a, * 1. Introduction
Osong Public Health Res Perspect 2012 3(2), 113e117 doi:10.1016/j.phrp.2012.04.004 pissn 2210-9099 eissn 2233-6052 - BRIEF REPORT - Multiplex Real-Time Polymerase Chain Reaction- Based Method for the Rapid
More informationNonmolecular Test for Detection of Low-Level Resistance to Fluoroquinolones in Streptococcus pneumoniae
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 2006, p. 572 579 Vol. 50, No. 2 0066-4804/06/$08.00 0 doi:10.1128/aac.50.2.572 579.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved.
More informationChapter 10 Microbial Genetics: New Genes for Old Germs
Chapter 10 Microbial Genetics: New Genes for Old Germs Objectives: After reading Chapter Ten, you should understand The structure and complexity of the bacterial chromosome and the significance of plasmids.
More informationRegulation of enzyme synthesis
Regulation of enzyme synthesis The lac operon is an example of an inducible operon - it is normally off, but when a molecule called an inducer is present, the operon turns on. The trp operon is an example
More informationgyra Mutations in Ciprofloxacin-resistant Clinical Isolates of Pseudomonas aeruginosa in a Silesian Hospital in Poland
Polish Journal of Microbiology 2005, Vol. 54, No 3, 201 206 gyra Mutations in Ciprofloxacin-resistant Clinical Isolates of Pseudomonas aeruginosa in a Silesian Hospital in Poland ZENOBIA WYDMUCH 1, OLGA
More informationAdvantages of genetic analysis in bacteria/phage. Selections vs Screens. Mutations. Mutations lecture: March 4, 2009
Mutations lecture: March 4, 2009 1. Genetic analysis of bacteria: the whys, hows, and whats 2. Luria-Delbrück and beyond: we still care! 3. Analysis of essential genes! RNA pol, merodiploids and amber
More informationChapter 9 Microbial Genetics
Chapter 9 Microbial Genetics You are expected to know details of 1) DNA replication 2) RNA synthesis (transcription) 3) Protein synthesis (translation) Genome & Genes A genome is all the genetic information
More informationACCEPTED. Goarant, 2 and S. Le Hello 1* Institut Pasteur de Nouvelle-Calédonie, Laboratoire d Epidémiologie Moléculaire, 1
AAC Accepts, published online ahead of print on August 00 Antimicrob. Agents Chemother. doi:0./aac.000-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationGenetics Lecture 21 Recombinant DNA
Genetics Lecture 21 Recombinant DNA Recombinant DNA In 1971, a paper published by Kathleen Danna and Daniel Nathans marked the beginning of the recombinant DNA era. The paper described the isolation of
More informationWhat determines if a mutation is deleterious, neutral, or beneficial?
BIO 184 - PAL Problem Set Lecture 6 (Brooker Chapter 18) Mutations Section A. Types of mutations Define and give an example the following terms: allele; phenotype; genotype; Define and give an example
More informationMutator phenotype confers advantage in Escherichia coli chronic urinary tract infection pathogenesis
FEMS Immunology and Medical Microbiology 44 (2005) 317 321 www.fems-microbiology.org Mutator phenotype confers advantage in Escherichia coli chronic urinary tract infection pathogenesis Francoise Labat
More informationChapter 8. Microbial Genetics. Lectures prepared by Christine L. Case. Copyright 2010 Pearson Education, Inc.
Chapter 8 Microbial Genetics Lectures prepared by Christine L. Case Structure and Function of Genetic Material Learning Objectives 8-1 Define genetics, genome, chromosome, gene, genetic code, genotype,
More informationMargaret Ip,* Shirley S. L. Chau, Fang Chi, Amy Qi, and Raymond W. M. Lai
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2006, p. 970 975 Vol. 44, No. 3 0095-1137/06/$08.00 0 doi:10.1128/jcm.44.3.970 975.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved. Rapid
More informationGenetic Adaptation II. Microbial Physiology Module 3
Genetic Adaptation II Microbial Physiology Module 3 Topics Topic 4: Topic 5: Transposable Elements Exchange of Genetic Material Between Organisms Topic 5a: Protection Against Foreign DNA Aims and Objectives
More informationMCB 421 Exam #1 (A) Fall There are 9 questions and 1 supplement on last page. Answer all 9 questions. Be sure your name is on each page
MCB 421 Exam #1 (A) Fall 2006 There are 9 questions and 1 supplement on last page. Answer all 9 questions. Be sure your name is on each page 1). (8 points) A Luria-Delbruck fluctuation test was done to
More informationAdaptation of a Bacterial Growth Detection Assay on the VICTOR Nivo Multimode Plate Reader for Measurement of Antibiotic Effects
APPLICATION NOTE Multimode Detection Authors: Maria Kuzikov Dr. Bernhard Ellinger Fraunhofer IME ScreeningPort Hamburg, Germany Adaptation of a Bacterial Growth Detection Assay on the VICTOR Nivo Multimode
More informationPERANAN MIKROBIOLOGI DALAM DIAGNOSIS PENYAKIT INFEKSI. dr. Agus Eka Darwinata, Ph.D.
PERANAN MIKROBIOLOGI DALAM DIAGNOSIS PENYAKIT INFEKSI dr. Agus Eka Darwinata, Ph.D. CLINICAL MICROBIOLOGY Clinical microbiology is the discipline of detection, characterization, and quantification of
More informationBIG DATA IN GENOMICS. Alex Wong March 14, 2016
BIG DATA IN GENOMICS Alex Wong March 14, 2016 Outline What is genomics? A brief history of DNA Next-generation sequencing How big is big genomic data? Case studies What s next? What is genomics? A genome
More informationKrzysztof Sieradzki and Alexander Tomasz* The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA
Journal of Antimicrobial Chemotherapy (1997) 39, Suppl. A, 47 51 JAC Suppression of -lactam antibiotic resistance in a methicillin-resistant Staphylococcus aureus through synergic action of early cell
More informationPathogenic bacteria replicate and persevere in ecological niches called reservoirs
TYPING METHODS WHAT IS TYPING AND WHAT ARE TYPING METHODS? Pathogenic bacteria replicate and persevere in ecological niches called reservoirs Reservoirs may be humans, including (fellow) patients and healthcare
More information4/3/2013. DNA Synthesis Replication of Bacterial DNA Replication of Bacterial DNA
4/3/03 3 4 5 6 7 8 9 0 Chapter 8 Microbial Genetics Terminology Genetics: The study of what genes are, how they carry information, how information is expressed, and how genes are replicated Gene: A segment
More informationBiofilm Protocol Optimization For Pseudomonas aeruginosa. Introduction. Materials and Methods. Culture Media, Incubation Time, and Biofilm Measurement
Biofilm Protocol Optimization For Pseudomonas aeruginosa Culture Media, Incubation Time, and Biofilm Measurement Introduction In addition to the conventional arsenal of antibiotic resistance mechanisms
More informationSUMMARY. Key words: antibioticresistance, Enterobacteriaceae, ESBL, CTX-M,
SUMMARY Key words: antibioticresistance, Enterobacteriaceae, ESBL, CTX-M, The doctoral thesis entitled Prevalence of Enterobacteriaceae producing extendedspectrum beta-lactamases (ESBL) isolated from broilers
More informationCHAPTER 2A HOW DO YOU BEGIN TO CLONE A GENE? CHAPTER 2A STUDENT GUIDE 2013 Amgen Foundation. All rights reserved.
CHAPTER 2A HOW DO YOU BEGIN TO CLONE A GENE? 35 INTRODUCTION In the Program Introduction, you learned that the increase in diabetes in the United States has resulted in a great demand for its treatment,
More informationSite-Directed Mutagenesis reveals Amino Acid Residues in the Escherichia coli RND Efflux ACCEPTED
AAC Accepts, published online ahead of print on 0 October 00 Antimicrob. Agents Chemother. doi:./aac.001-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationCHAPTER 24. Immunology
CHAPTER 24 Diagnostic i Microbiology and Immunology Growth-Dependent Diagnostic Methods Isolation of Pathogens from Clinical Specimens Proper sampling and culture of a suspected pathogen is the most reliable
More informationLaboratory Testing for Diagnosis and Treatment of TB
Laboratory Testing for Diagnosis and Treatment of TB Jennifer Rakeman, PhD Associate Director and Microbiology Manager Public Health Laboratory NYC Department of Health and Mental Hygiene Laboratory diagnosis
More informationMCB 421 First Exam October 4, 2004
1. (10 pts). An E. coli strain (strain A) that lacks an inducing prophage and carries the F factor is heavily irradiated with UV light and then mixed 1:1 with a second E. coli strain (strain B) that carries
More information2 nd year Medical Students - JU Bacterial genetics. Dr. Hamed Al Zoubi Associate Professor of Medical Microbiology. MBBS / J.U.S.
2 nd year Medical Students - JU Bacterial genetics Dr. Hamed Al Zoubi Associate Professor of Medical Microbiology. MBBS / J.U.S.T MSc, PhD/ UK Bacterial genetics ILOs: bacterial genome and replication
More information4 Mutant Hunts - To Select or to Screen (Perhaps Even by Brute Force)
Genetic Techniques for Biological Research Corinne A. Michels Copyright q 2002 John Wiley & Sons, Ltd ISBNs: 0-471-89921-6 (Hardback); 0-470-84662-3 (Electronic) 4 Mutant Hunts - To Select or to Screen
More informationReceived 5 October 2014; returned 4 November 2014; revised 9 November 2014; accepted 8 December 2014
J Antimicrob Chemother 2015; 70: 1547 1551 doi:10.1093/jac/dku548 Advance Access publication 27 January 2015 Risk factors for ambulatory urinary tract infections caused by high-mic fluoroquinolone-susceptible
More informationRole of hypermutability on bacterial tness and emergence of resistance in experimental osteomyelitis due to Staphylococcus aureus
RESEARCH ARTICLE Role of hypermutability on bacterial tness and emergence of resistance in experimental osteomyelitis due to Staphylococcus aureus Claire Daurel 1,2, Anne-Laure Prunier 2, Françoise Chau
More informationThe impact of different combinations of resistance associated mutations on fluoroquinolone resistance in Escherichia coli.
The impact of different combinations of resistance associated mutations on fluoroquinolone resistance in Escherichia coli Marja Rasinperä Degree project in biology, 2006 Examensarbete i biologi 10 p, 2006
More informationSupporting Information-Tables
Supporting Information-Tables Table S1. Bacterial strains and plasmids used in this work Bacterial strains Description Source of reference Streptococcus pneumoniae 1 Cp1015 non-capsulated and βl susceptible
More informationCan whole genome sequencing replace AST?
Can whole genome sequencing replace AST? Matthew J Ellington Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown copyright EUCAST Subcommittee on the role of whole
More informationAntibiotic Resistance Genes: From The Farm To The Human Gut
Shanghai 2015 Antibiotic Resistance Genes: From The Farm To The Human Gut Baoli Zhu, PhD Institute of Microbiology, Chinese Academy Beijing Key Lab of Microbial Drug Resistance and Resistome zhubaoli@im.ac.cn
More informationABC. Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline. Volume 19 Number 18
M26-A ISBN 1-56238-384-1 September 1999 ISSN 0273-3099 Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline Volume 19 Number 18 Arthur L. Barry, Ph.D. William A. Craig,
More informationchapter eight: microbial genetics
chapter eight: microbial genetics Revised 9/15/2016 the hereditary material Griffith 1927 & Avery, et al. 1944 the transforming principle coined by Griffith, identified by Avery the hereditary material
More informationMolecular Biology Midterm Exam 2
Molecular Biology Midterm Exam 2 1. The experiments by Frank Stahl and Matthew Messelson demonstrated that DNA strands separate during DNA replication. They showed that DNA replication is what kind of
More informationLandscape and Language of Molecular Diagnostics for TB Drug Resistance
Landscape and Language of Molecular Diagnostics for TB Drug Resistance Purpose This module will provide: A brief overview of basic principles of molecular biology An introduction to mutations and their
More informationChapter 9 Preview - DNA
Chapter 9 Preview - DNA Multiple Choice Identify the choice that best completes the statement or answers the question. 1. In order to show that DNA in cell extracts is responsible for genetic transformation
More informationBacterial Genetics. Prof. Dr. Asem Shehabi Faculty of Medicine University of Jordan
Bacterial Genetics Prof. Dr. Asem Shehabi Faculty of Medicine University of Jordan Bacterial Genes-1 All patterns of growth, metabolism, essential cellular structures, biological characteristics of bacteria
More informationBACTERIAL GENETICS. How does the DNA in the bacterial cell replicate
BACTERIAL GENETICS Bacterial genetics is the study of gene structure and function in bacteria. Genetics itself is concerned with determining the number, location, and character of the genes of an organism.
More informationGenetic analysis is extremely powerful, but also limited in the absence of other types of information
Genetic analysis is extremely powerful, but also limited in the absence of other types of information Mendel was interested in variation among peas as a formalism - because he realized that these phenotypes
More informationUnderstanding the Cellular Mechanism of the Excess Microsporocytes I (EMSI) Gene. Andrew ElBardissi, The Pennsylvania State University
Understanding the Cellular Mechanism of the Excess Microsporocytes I (EMSI) Gene Andrew ElBardissi, The Pennsylvania State University Abstract: Hong Ma, The Pennsylvania State University The Excess Microsporocytes
More informationWhat Are We Trying to Say Here? Standardizing Next Generation Sequencing Reports for Tuberculosis
Jeffrey Tornheim, MD MPH Clinical Fellow in Infectious Diseases Johns Hopkins University School of Medicine tornheim@jhu.edu What Are We Trying to Say Here? Standardizing Next Generation Sequencing Reports
More informationBacterial Genetics. Stijn van der Veen
Bacterial Genetics Stijn van der Veen Differentiating bacterial species Morphology (shape) Composition (cell envelope and other structures) Metabolism & growth characteristics Genetics Differentiating
More informationLecture 1. Basic Definitions and Nucleic Acids. Basic Definitions you should already know
Lecture 1. Basic Definitions and Nucleic Acids Basic Definitions you should already know apple DNA: Deoxyribonucleic Acid apple RNA: Ribonucleic Acid apple mrna: messenger RNA: contains the genetic information(coding
More informationBacterial Mutation Types Mechanisms And Mutant Detection
Bacterial Mutation Types Mechanisms And Mutant Detection 1 / 5 2 / 5 3 / 5 Bacterial Mutation Types Mechanisms And Substitution of a nucleotide and Deletion or addition of them is. two mechanisms of mutation.
More informationnumber Done by Corrected by Doctor Hamed Al Zoubi
number 3 Done by Neda a Baniata Corrected by Waseem Abu Obeida Doctor Hamed Al Zoubi Note: it is important to refer to slides. Bacterial genetics *The main concepts we will talk about in this lecture:
More informationJingwen Wang. Why do mutations to fluoroquinolone resistance correlate with the presence of ESBL plasmids in E. coli?
Why do mutations to fluoroquinolone resistance correlate with the presence of ESBL plasmids in E. coli? Jingwen Wang Degree project in biology, Master of science (2 years), 2011 Examensarbete i biologi
More informationPenicillin Streptomycin
BTEC 4200 Name Fall 2005 Exam 2 A. Multiple choice (2 pt each) The following choices are used for questions 1 5. Trypan red Arspheniamine (Salvarsan) Sulfonamide Penicillin Streptomycin 1. This substance,
More informationReservoir of Bacterial Exotoxin Genes in the Environment
Reservoir of Bacterial Exotoxin Genes in the Environment Veronica Casas, Joseph Magbanua, Gerico Sobrepeña, and Stanley Maloy * Center for Microbial Sciences San Diego State University 5500 Campanile Drive
More informationTime allowed: 2 hours Answer ALL questions in Section A, ALL PARTS of the question in Section B and ONE question from Section C.
UNIVERSITY OF EAST ANGLIA School of Biological Sciences Main Series UG Examination 2013-2014 MOLECULAR BIOLOGY BIO-2B02 Time allowed: 2 hours Answer ALL questions in Section A, ALL PARTS of the question
More informationgenerated by the usage of antimicrobial drugs is absent. She is the author of 14 publications in international journals.
Fernando Baquero Doctor in Medicine, Ramón y Cajal Research Professor in Bacterial Evolution at the Biomedical Research Foundation and Department of Microbiology of the Ramón y Cajal Universty Hospital.
More informationA novel approach for comparing quinolones for emergence of resistant mutants during quinolone exposure
AAC Accepts, published online ahead of print on 5 October 2009 Antimicrob. Agents Chemother. doi:10.1128/aac.01035-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationSimulation-based statistical inference in computational biology
Simulation-based statistical inference in computational biology Case study: modeling the genome evolution of Streptococcus pneumoniae Pekka Marttinen, Nicholas J. Croucher, Michael U. Gutmann, Jukka Corander,
More informationDetection of grla and gyra Mutations in 344 Staphylococcus aureus Strains
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 1998, p. 236 240 Vol. 42, No. 2 0066-4804/98/$04.00 0 Copyright 1998, American Society for Microbiology Detection of grla and gyra Mutations in 344 Staphylococcus
More informationDetection of grla and gyra Mutations in 344 Staphylococcus aureus Strains
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 1998, p. 236 240 Vol. 42, No. 2 0066-4804/98/$04.00 0 Copyright 1998, American Society for Microbiology Detection of grla and gyra Mutations in 344 Staphylococcus
More informationBacterial Genetics, BIO 4443/6443 Fall Semester 2002 Exam I. Name Answer Key
Name Answer Key Student pid# Bacterial Genetics, BIO 4443/6443 Fall Semester 2002 Exam I 1.) What is a sigma factor? Why does the cell contain multiple sigma factors? (5pts) Sigma Is a subunit of the RNA
More informationchapter eight: microbial genetics
chapter eight: microbial genetics the hereditary material Griffith 1927 & Avery, et al. 1944 the transforming principle coined by Griffith, identified by Avery the hereditary material Hershey Chase, 1952
More informationAntimicrobial and Antibacterial Agents
Antimicrobial and Antibacterial Agents Contents Introduction Classification of antimicrobial drugs Special terms Mechanism of action Resistance of antimicrobial agent Introduction Joseph Lister 1867 -
More informationForecast diagnostics for antimicrobial resistance (AMR)
Forecast diagnostics for antimicrobial resistance (AMR) Authors: Ann Van den Bruel, Philip Turner NIHR Diagnostic Evidence Cooperative Oxford, University of Oxford Context When asked to make forecasts
More informationSusceptibility Tests
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1982, p. 213-217 Vol. 16, No. 2 0095-1137/82/080213-05$02.00/0 In Vitro Studies with Cefotaxime: Disk Diffusion Susceptibility Tests SMITH SHADOMY* AND EDWARD L.
More informationPseudomonas aeruginosa
Pseudomonas aeruginosa Myth or Menace? Megan Hargreaves and Sharri Minion Why focus on Pseudomonas aeruginosa? Well known to environmental microbiologists Indigenous microbiota of water and soil, plant
More informationby author How to effectively report laboratory findings to clinicians (Breakpoints and Interpretation)
How to effectively report laboratory findings to clinicians (Breakpoints and Interpretation) A Vatopoulos National School of Public Health & Central Public Health Laboratory KEELPNO Antibiotic Activity
More informationCloning and Characterization of E. meningoseptica Beta Lactamase
Cloning and Characterization of E. meningoseptica Beta Lactamase Authors: Lindsey Purcell, Jessica Matts, Patricia Canaan* Department of Biochemistry and Molecular Biology Abstract Elizabethkingia meningoseptica
More informationStability of Antibiotics and Chemotherapeutics in
APPUED MICROBIOLOGY, Sept. 1970, p. 447-451 Copyright 1970 American Society for Microbiology Vol. 20, No. 3 Printed in U.S.A. Stability of Antibiotics and Chemotherapeutics in Agar Plates KENNETH J. RYAN,
More informationMature Pseudomonas aeruginosa Biofilms Prevail Compared to Young Biofilms in the
AAC Accepts, published online ahead of print on 9 July 2012 Antimicrob. Agents Chemother. doi:10.1128/aac.00650-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Mature Pseudomonas
More informationAntimicrobial Agents and Chemotherapy New Data Letter
AAC Accepted Manuscript Posted Online 15 August 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.01519-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 Antimicrobial Agents
More informationCan mutations ever be good? Modern Synthesis II. Can mutations ever be good? Can mutations ever be good? Ch-ch-ch-changes...
Can mutations ever be good? Modern Synthesis II Ch-ch-ch-changes... BIOL 4415: Evolution Dr. Ben Waggoner Can mutations ever be good? Beginning in the 1970s, Barry Hall developed a strain of the bacterium
More informationBACTERIAL ADAPTATION TO NOVEL SELECTION PRESSURES
Microbiology and Tumor Biology Center Karolinska Institutet and Swedish Institute for Infectious Disease Control, Stockholm Sweden BACTERIAL ADAPTATION TO NOVEL SELECTION PRESSURES ANNIKA NILSSON STOCKHOLM
More informationAntimicrobial Drugs. Antimicrobial Drugs. The dawn of antibiotics. Alexander Fleming. Chain and Florey. Antibiotics
Antimicrobial Drugs Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease Antimicrobial drugs: Interfere with the growth of microbes within a host Antibiotic: Substance produced by a microbe
More information# ml too many to count # ml 161/173 # ml 4/1
Biol 322 Fall 2012 Study Sheet for Quiz #2 Quiz #2 is scheduled for Thursday Nov 10 th and will be worth 30-40 pts. This quiz will cover: Mutagenesis Lab: Parts 1 & 2 Bacterial Genetics: F X F- Cross All
More informationAntibiotic Susceptibility Testing (ABST/AST)
Antibiotic Susceptibility Testing (ABST/AST) Goal Offer guidance to physicians in selecting effective antibacterial therapy for a pathogen in a specific body site. Performed on bacteria isolated from clinical
More information7.1 Techniques for Producing and Analyzing DNA. SBI4U Ms. Ho-Lau
7.1 Techniques for Producing and Analyzing DNA SBI4U Ms. Ho-Lau What is Biotechnology? From Merriam-Webster: the manipulation of living organisms or their components to produce useful usually commercial
More informationGame Plan. Lecture. Lab. Biofilms Review of basic genetics Bacterial gene structure Gene regulation Mutations
Game Plan Lecture Biofilms Review of basic genetics Bacterial gene structure Gene regulation Mutations Lab Review serial dilutions and Calculate generation times Effects on growth: temp, ph, O2 Pre-labs
More informationEmergence of a mutl Mutation Causing MLST-PFGE. Discrepancy among Pseudomonas aeruginosa Isolates from. a Cystic Fibrosis Patient
JCM Accepts, published online ahead of print on 8 February 2012 J. Clin. Microbiol. doi:10.1128/jcm.05478-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 Emergence of a
More informationExam 2 Biology II Winter 2013
Exam 2 Biology II Winter 2013 Name: Notice that on the last page of this exam, you will find a genetic code table and some potentially useful sequences. You can tear it off to make it more useful. This
More informationLac Operon contains three structural genes and is controlled by the lac repressor: (1) LacY protein transports lactose into the cell.
Regulation of gene expression a. Expression of most genes can be turned off and on, usually by controlling the initiation of transcription. b. Lactose degradation in E. coli (Negative Control) Lac Operon
More informationIsolation of Lac+ Mutants from a Lac- Strain of Escherichia coli, by the Replica Plating Technique
586 BANI^, S. (1958). J. gen. Microbiol. 18, 586-590 Isolation of Lac+ Mutants from a Lac- Strain of Escherichia coli, by the Replica Plating Technique BY S. BANIC Institute of Microbiology, Medical Faculty,
More informationNovel Approach for Comparing the Abilities of Quinolones To Restrict the Emergence of Resistant Mutants during Quinolone Exposure
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 2010, p. 149 156 Vol. 54, No. 1 0066-4804/10/$12.00 doi:10.1128/aac.01035-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. Novel Approach
More informationPlease sign below if you wish to have your grades posted by the last five digits of your SSN
BIO 226R EXAM III (Sample) PRINT YOUR NAME Please sign below if you wish to have your grades posted by the last five digits of your Signature BIO 226R Exam III has 8 pages, and 26 questions. There are
More informationMUTANT: A mutant is a strain that has suffered a mutation and exhibits a different phenotype from the parental strain.
OUTLINE OF GENETICS LECTURE #1 A. TERMS PHENOTYPE: Phenotype refers to the observable properties of an organism, such as morphology, growth rate, ability to grow under different conditions or media. For
More informationTodd A. Davies, 1 Alan Evangelista, 1 Sharon Pfleger, 1 Karen Bush, 2 Daniel F. Sahm, 3 and Raul Goldschmidt 2 *
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 2002, p. 119 124 Vol. 46, No. 1 0066-4804/02/$04.00 0 DOI: 10.1128/AAC.46.1.119 124.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.
More informationThe Mosaic Nature of Genomes
The Mosaic Nature of Genomes n DNA sequence is not static Mutations of single bases Large deletions Large insertions of sequence n Transferred from other species n New functions useful in particular situations
More informationStay or Go: A Study on Oxygen Tension on the Biofilm Formation of Cystic Fibrosis Bacteria. Honors Project. In fulfillment of the Requirements for
Stay or Go: A Study on Oxygen Tension on the Biofilm Formation of Cystic Fibrosis Bacteria Honors Project In fulfillment of the Requirements for The Esther G. Maynor Honors College University of North
More informationEffect of E. coli topa mutation on SOS and Antibiotic Response
Effect of E. coli topa mutation on SOS and Antibiotic Response Presentation by Jenny Yang Board of Education Meeting February 27, 2012 NY Medical College Dr. Yuk Ching Tse-Dinh Introduction Prevalent use
More informationMIC & Etest. Dr. M. Talebi Ph.D of Bacteriology Tehran University of Medical Sciences
MIC & Etest Dr. M. Talebi Ph.D of Bacteriology Tehran University of Medical Sciences MIC The minimum inhibitory concentration (MIC) is defined as the lowest concentration of the antimicrobial agent required
More informationLab 5/5a Transformation of E. coli with a Recombinant Plasmid
Lab 5/5a Transformation of E. coli with a Recombinant Plasmid Lab 2 Pre Lab Readiness Familiarity and Proper use of micropipettes Remember the 1 st and 2 nd stops Aseptic Technique Antibiotic Resistance
More informationGenetics. Chapter 9 - Microbial Genetics. Chromosome. Genes. Topics - Genetics - Flow of Genetics - Regulation - Mutation - Recombination
Chapter 9 - Microbial Genetics Topics - Genetics - Flow of Genetics - Regulation - Mutation - Recombination Genetics Genome (The sum total of genetic material of a cell is referred to as the genome.) Chromosome
More informationUse of Molecular Assays for Resistance Detection
Use of Molecular Assays for Resistance Detection Antimicrobial resistance and susceptibility are complex, and current in vitro methods have been developed to predict a microorganism s response to antibacterial
More informationAntibiotics and alternative strategies to control infections
Antibiotics and alternative strategies to control infections http://blog.microbiologics.com/wpcontent/uploads/2015/12/acinetob acter-baumannii-232x300.jpg www.biochemj.org/bj/330/0581/bj3300581.htm ciss.blog.olemiss.edu
More information01/08/2018. Control of Microbial Growth. Methods. Terminology. Disinfectants and Antiseptics. Three approaches. Cleaning. Chemical.
Control of Microbial Growth Disinfectants and Antiseptics 1 Methods 2 Three approaches Chemical Disinfectants and antiseptics Physical Heat Ultraviolet Irradiations Mechanical elimination Cleaning Filtration
More information